Image visibility of cancer to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer

BJU International

Volumn 111, Issue 8, 2013, Pages

  Ukimura, Osamu ^a   De Castro Abreu, Andre Luis ^a   Gill, Inderbir S ^a   Shoji, Sunao ^a   Hung, Andrew J ^a   Bahn, Duke ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

focal therapy; image visibility; prostate biopsy; prostate cancer; ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CRYOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; IMAGE GUIDED BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; ULTRASOUND SCANNER;

AGED; AGED, 80 AND OVER; BIOPSY; CRYOSURGERY; ENDOSONOGRAPHY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER; URETHRA;

EID: 84878327691     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12124     Document Type: Article

References (37)

1. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-213
2. Bahn D, Abreu AC, Gill IS, et al. Focal cryotherapy for clinically unilateral low-intermediate risk prostate cancer in 73 men with median 3.7-year follow-up. Eur Urol 2012; 62: 55-63
3. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J,. The 'male lumpectomy': focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26: 500-505
4. Ahmed HU, Freeman A, Kirkham A, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol 2011; 185: 1246-1255
5. Ahmed HU, Hindley RG, Dickinson L, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 2012; 13: 622-632
6. Onik G, Miessau M, Bostwick DG,. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 2009; 27: 4321-4326
7. Kasivisanathan V, Dufour R, Moore CM, et al. Transperineal magnetic resonance image-targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 2013; 189: 860-866
8. Tareen B, Godoy G, Sankin A, et al. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009; 104: 195-199
9. Falzarano SM, Zhou M, Hernandez AV, et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology 2010; 76: 682-687
10. Ukimura O, Coleman JA, de la Taille A, et al. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol 2012; 63: 214-230
11. Eggener SE, Mueller A, Berglund RK, et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2009; 181: 1635-1641
12. Dall'Era MA, Konety BR, Cowan JE, et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008; 112: 2664-2670 (Pubitemid 351969209)
13. Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63: 125-140
14. Toi A, Neill MG, Lockwood GA, et al. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007; 177: 516-520 (Pubitemid 46054011)
15. Lawrentschuk N, Fleshner N,. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int 2009; 103: 730-733
16. Moore CL, Copel JA,. Point-of-care ultrasonography. N Engl J Med 2011; 364: 749-757
17. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ,. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology 2007; 70: 1136-1140 (Pubitemid 350297373)
18. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ,. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010; 76: 1025-1033
19. Villers A, Puech P, Mouton D, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006; 176: 2432-2437 (Pubitemid 44665992)
20. Ohori M, Eastham JA, Koh H, et al. Is focal therapy reasonable in patients with early stage prostate cancer (CAP)?an analysis of radical prostatectomy (RP) specimens. J Urol 2006; AUA Annual Meeting, Atlanta 2006. Abstract # 1574 175 (Suppl).), 507
21. Sartor AO, Hricak H, Wheeler TM, et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology 2008; 72 (6 Suppl): S12-24
22. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR,. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int 2012; 110: 50-55
23. Lecornet E, Ahmed HU, Hu Y, et al. The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. J Urol 2012; 188: 974-980
24. Ukimura O, Magi-Galluzzi C, Gill IS,. Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: impact on surgical margins. J Urol 2006; 175: 1304-1310
25. Eisenberg ML, Cowan JE, Davies BJ, et al. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer. Urol Oncol 2011; 29: 171-176
26. Scales CD Jr, Presti JC Jr, Kane CJ, et al. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy-results from the SEARCH database. J Urol 2007; 178 (4 Pt 1): 1249-1252 (Pubitemid 47376716)
27. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M,. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106: 1607-1611
28. Brame RS, Zaider M, Zakian KL, et al. Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 2009; 74: 110-114
29. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252: 449-457
30. Mitterberger M, Pinggera GM, Horninger W, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 2007; 178: 464-468 (Pubitemid 47030488)
31. Tsutsumi M, Miyagawa T, Matsumura T, et al. Real-time balloon inflation elastography for prostate cancer detection and initial evaluation of clinicopathologic analysis. AJR Am J Roentgenol 2010; 194: W471-476
32. Pinto PA, Chung PH, Ratinehad AR, et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011; 186: 1281-1285
33. Ukimura O, Desai M, Palmer S, et al. Accuracy of 3D elastic registration system of prostate biopsy location by real-time 3D TRUS guidance with MR/TRUS image fusion: pilot phantom Study. J Urol 2012; 187: 1080-1086
34. Ukimura O, Troncoso P, Ramirez EI, Babaian RJ,. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension. J Urol 1998; 159: 1251-1259 (Pubitemid 28172808)
35. Dudea SM, Giurgiu CR, Dumitriu D, et al. Value of ultrasound elastography in the diagnosis and management of prostate carcinoma. Med Ultrason 2011; 13: 45-53
36. Lawrentschuk N, Toi A, Lockwood GA, et al. Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy. J Urol 2009; 182: 2659-2663
37. Smeenge M, Barentsz J, Cosgrove D, et al. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU Int 2012; 110: 942-948